Hospira Recalls Carboplatin Injection Vials Due to pH Specification Failure
Hospira Inc. is recalling 77,542 vials of Carboplatin Injection because the active ingredient lots trended out of specification for low pH.
- Product
- CARBOPLATIN — CARBOPLATIN (CARBOPLATIN)
- Category
- Drug
- Distribution
- Distributed nationwide